AXIM Biotechnologies, Inc.
AXIM
$0.003
$0.000.00%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 39.04% | 89.42% | -111.57% | 116.15% | -204.54% |
| Total Depreciation and Amortization | 1.22% | 1.12% | 0.00% | 0.09% | 0.75% |
| Total Amortization of Deferred Charges | 46.02% | -22.95% | -27.54% | -26.00% | -66.34% |
| Total Other Non-Cash Items | -59.45% | -92.86% | 1,037.68% | -188.94% | 785.41% |
| Change in Net Operating Assets | 11,782.40% | -392.17% | 31.59% | -42.19% | 71.00% |
| Cash from Operations | 185.92% | -651.48% | 106.21% | 17.65% | 8.57% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -82.61% | -- | -- | 100.00% | 1,105.45% |
| Total Debt Repaid | -- | -- | 100.00% | 100.00% | -100.00% |
| Issuance of Common Stock | -- | 420.11% | -94.17% | -63.51% | -60.68% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -193.62% | 581.65% | -42.86% | -54.98% | 87.36% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -306.14% | -1,047.62% | 214.33% | -175.35% | 112.83% |
